ACTINIUM PHARMACEUTICALS, INC. Operating Lease Liability
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Operating Lease Liability of $1.42 million as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-05-09
- 2025-03-31: Operating Lease, Liability $1.42M.
- 2024-12-31: Operating Lease, Liability $1.55M.
- 2024-03-31: Operating Lease, Liability $1.95M.
- 2023-09-30: Operating Lease, Liability $2.08M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-03-31 | $1.42M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.55M 10-K · filed 2025-03-31 |
| 2024-03-31 | $1.95M 10-Q · filed 2024-04-26 |
| 2023-09-30 | $2.08M 10-K · filed 2024-03-29 |
| 2008-12-31 | $2.21M 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |